New hope for Hard-to-Treat cancers: DB-1310 enters human trials
NCT ID NCT05785741
First seen Apr 23, 2026 · Last updated Apr 30, 2026 · Updated 2 times
Summary
This study tests a new drug called DB-1310 in people with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if it can shrink tumors. About 1,000 adults will take part in two phases: first to check safety, then to measure how well the drug works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital of Jiangnan University
RECRUITINGWuxi, Jiangsu, 214000, China
Contact
-
BRCR Medical Center Inc.
RECRUITINGTamarac, Florida, 33321, United States
Contact
-
BRCR global
RECRUITINGPlantation, Florida, 33322, United States
Contact
-
Carl & Edyth Lindner Center for Research & Education at The Christ Hospital and The Christ Hospital Cancer Center
RECRUITINGCincinnati, Ohio, 45219, United States
Contact
-
D&H Cancer Research Center LLC
WITHDRAWNMargate, Florida, 33063, United States
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact
-
Florida Cancer Specialists
RECRUITINGSarasota, Florida, 34232, United States
Contact
-
Henan Cancer Hospital
RECRUITINGZhengzhou, Henan, 450003, China
Contact
-
Henry Ford Health System
RECRUITINGDetroit, Michigan, 48202, United States
Contact
-
Hunan cancer hospital
RECRUITINGChangsha, Hunan, 410000, China
Contact
-
Jiangsu Province hospital
RECRUITINGNanjing, Jiangsu, 210000, China
Contact
-
NEXT Virginia
RECRUITINGFairfax, Virginia, 22031, United States
Contact
-
Research Site 111
RECRUITINGAtlanta, Georgia, 30322, United States
Contact
-
Research Site 117
WITHDRAWNCoral Gables, Florida, 33146, United States
-
Research Site 222
RECRUITINGChengdu, Sichuan, 610041, China
-
Research site 119
ACTIVE_NOT_RECRUITINGFlorham Park, New Jersey, 07932, United States
-
Sarah Cannon Research Institute at Florida Cancer Specialists
RECRUITINGOrlando, Florida, 32827, United States
Contact
-
Shanghai Chest Hospital
RECRUITINGShanghai, Shanghai Municipality, 200030, China
Contact
-
Sichuan Provincial People's Hospital
RECRUITINGChengdu, Sichuan, 610030, China
Contact
-
Tennessee Oncology, PLLC
RECRUITINGNashville, Tennessee, 37203, United States
Contact
-
The First Hospital of China Medical University
RECRUITINGShenyang, Liaoning, 110010, China
Contact
-
The first hospital of Jilin University
RECRUITINGChangchun, Jilin, 130021, China
Contact
-
UCLA Hematology/Oncology - Santa Monica
RECRUITINGSanta Monica, California, 90404, United States
Contact
-
University of California, Davis Comprehensive Cancer Center
RECRUITINGSacramento, California, 95817, United States
Contact
Conditions
Explore the condition pages connected to this study.